Telmisartan vs. enalapril in type 2 diabetes.
Loewenstein
Joseph E
JE
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000191:economics* / Q000627:therapeutic use; D001565:Benzoates / Q000191:economics* / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D004656:Enalapril / Q000191:economics* / Q000627:therapeutic use; D005252:Fees, Pharmaceutical; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D000077333:Telmisartan
D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D004656:Enalapril; D000077333:Telmisartan